FD
Farmaceutica Lda Defiante
10% Owner

Farmaceutica Lda Defiante insider trades: Sciclone Pharmaceuticals (SCLN) stock buys and sales

10% Owner, Sciclone Pharmaceuticals Last trade Apr 30, 2012 32 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
32
Open-market trades
since 2005
4
Companies
last trade 2012

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Farmaceutica reports to the SEC

Open-market buys and sales

32 trades reported on SEC Form 4, newest first

DateStockTypeValue
Apr 30, 2012SCLN↓ Sell$33.2M
Jan 5, 2011RGRX.OB↑ Buy$250K
Jan 30, 2008SCLN↑ Buy$59K
Jan 28, 2008SCLN↑ Buy$820
Jan 25, 2008SCLN↑ Buy$74K
Jan 23, 2008SCLN↑ Buy$59K
Jan 16, 2008SCLN↑ Buy$128K
Jan 14, 2008SCLN↑ Buy$57K
Nov 20, 2007QSC↑ Buy$11.5M
Nov 20, 2007QSC↓ Sell$11.5M
Nov 13, 2007SCLN↑ Buy$112K
Nov 8, 2007SCLN↑ Buy$36K
Nov 5, 2007SCLN↑ Buy$82K
Nov 2, 2007SCLN↑ Buy$111K
Oct 19, 2007SCLN↑ Buy$51K
Oct 18, 2007SCLN↑ Buy$85K
Oct 16, 2007SCLN↑ Buy$144K
Oct 2, 2007SCLN↑ Buy$47K
Dec 21, 2006RGN↑ Buy$1.5M
Dec 20, 2006QSC↓ Sell$13.0M
Dec 20, 2006QSC↑ Buy$7.1M
Dec 20, 2006QSC↑ Buy$7.1M
Dec 20, 2006QSC↓ Sell$1.1M
Dec 13, 2006QSC↑ Buy$1.0M
Mar 6, 2006RGN↑ Buy$2.1M
Jun 22, 2005RGN↑ Buy$1000K
Jun 17, 2005SCLN↑ Buy$645K
Jun 16, 2005SCLN↑ Buy$333K
Jun 13, 2005SCLN↑ Buy$627K
Jun 1, 2005SCLN↑ Buy$18K
May 26, 2005SCLN↑ Buy$243K
May 25, 2005SCLN↑ Buy$357K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Farmaceutica Lda Defiante's insider trades

Farmaceutica Lda Defiante is a 10% owner of Sciclone Pharmaceuticals (SCLN). Since May 25, 2005, Farmaceutica has reported 28 open-market purchases worth $34.6M and 4 sales worth $58.8M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (6 filings), other transactions (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SCLN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.